The World's Most Dangerous Swing Trader
The World's Most Dangerous Swing Trader
 |
Celldex shows accelerating clinical progress and robust liquidity that together favor a positive near-term price bias. Technical signals point toward renewed upside momentum while fundamentals highlight a heavy R&D spend offset by a deep cash runway. |
 |
Applied Materials enters the weeks ahead with a bullish technical backdrop but clear near-term operational risk from China-related demand shifts. Fundamentals show healthy cash generation and above-average returns that underpin a valuation the WMDST model regards as under-valued. |
 |
Regulatory approvals and landmark Phase 3 data have propelled Ionis toward near-term commercial expansion while valuation metrics and technicals point to a strong but potentially volatile uptrend. |
 |
ALROSA shows operating resilience after an above-estimate EPS print while technical momentum signals limited upside in the coming weeks. Fundamental cash flow strength and low leverage contrast with soft revenue growth and cooling momentum. |
Sphere Entertainment reports strong content momentum alongside a structural debt reset that creates asymmetric near-term pressure on valuation and share performance.
 |
10x Genomics shows mixed signals: strong cash and margin fundamentals contrast with weakening technical momentum, creating a short-term environment where mean-reversion trades could appear. WMDST values the stock as under-valued. |
 |
Cactus reports a cash-rich balance sheet and ongoing strategic expansion while operating margins and near-term earnings show contraction. Technical indicators suggest short-term upside potential inside a still-rangebound longer-term trend. |
 |
Strong commercial traction for the company’s CAR-T franchise and sizeable cash reserves support a constructive near-term setup, even as technical momentum shows mixed directional signals. |
 |
Central Garden & Pet Company shows expanded margins and strong cash conversion while the current WMDST valuation registers the stock as under-valued; near-term price action will depend on whether operational gains translate into renewed buying interest. |
 |
FormFactor enters the coming weeks with constructive technical momentum and revenue mix gains while fundamental cash-generation lag threatens to cap market confidence. Near-term action should follow momentum signals tied to probe‑card strength. |